Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
3,05 CAD | +2,35% |
|
-6,44% | +12,96% |
Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Michael Kelly
CEO | Chief Executive Officer | 59 | 10/04/23 |
Bill Adams
DFI | Director of Finance/CFO | 62 | 24/02/20 |
Daniel Mikol
CTO | Chief Tech/Sci/R&D Officer | - | 05/05/21 |
Adam Rogers
BRD | Director/Board Member | - | 14/07/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Randall Kaye
BRD | Director/Board Member | 61 | 28/10/20 |
Brian Bayley
BRD | Director/Board Member | 71 | 16/05/18 |
Michael Kelly
CEO | Chief Executive Officer | 59 | 10/04/23 |
Harold Punnett
FOU | Founder | 67 | 19/01/17 |
John Thompson
BRD | Director/Board Member | 57 | 13/04/22 |
John Ruffolo
BRD | Director/Board Member | - | 17/10/23 |
Glenn Ives
CHM | Chairman | 62 | 01/09/21 |
Adam Rogers
BRD | Director/Board Member | - | 14/07/22 |
Director/Board Member | - | 01/09/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 69 977 649 | 53 864 835 ( 76,97 %) | 0 | 76,97 % |
Coordinate società
NervGen Pharma Corp.
112-970 Burrard Street Unit 1290
V6Z 2R4, Vancouver
+778-731-1711
http://www.nervgen.com![Indirizzo NervGen Pharma Corp.(NGEN)](https://cdn.zonebourse.com/static/address/55763923.png)
Settore
Vendite per regione
![Consenso](/images/consensus_flch.gif)
Fatturato trimestrale - Indice di sorpresa
Variaz. 1 gen. | Capi. | |
---|---|---|
+12,96% | 153 Mln | |
+22,10% | 47,07 Mrd | |
+46,45% | 42,06 Mrd | |
-3,12% | 39,98 Mrd | |
+36,10% | 33,02 Mrd | |
-6,30% | 27,9 Mrd | |
+18,71% | 27,63 Mrd | |
+46,15% | 14,37 Mrd | |
+44,52% | 13,45 Mrd | |
+0,19% | 12,03 Mrd |
- Borsa valori
- Azioni
- Azione NGEN
- Società NervGen Pharma Corp.